Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Advances in postoperative adjuvant therapy for primary liver cancer.
Zeng ZM, Mo N, Zeng J, Ma FC, Jiang YF, Huang HS, Liao XW, Zhu GZ, Ma J, Peng T. Zeng ZM, et al. World J Gastrointest Oncol. 2022 Sep 15;14(9):1604-1621. doi: 10.4251/wjgo.v14.i9.1604. World J Gastrointest Oncol. 2022. PMID: 36187393 Free PMC article. Review.
Comprehensive investigation of p53, p21, nm23, and VEGF expression in hepatitis B virus-related hepatocellular carcinoma overall survival after hepatectomy.
Zhu GZ, Liao XW, Wang XK, Gong YZ, Liu XG, Yu L, Han CY, Yang CK, Su H, Huang KT, Yu TD, Huang JL, Li J, Zeng ZM, Qin W, Liu ZQ, Zhou X, Liu JQ, Lu L, Han QF, Shang LM, Ye XP, Peng T. Zhu GZ, et al. Among authors: zeng zm. J Cancer. 2020 Jan 1;11(4):906-918. doi: 10.7150/jca.33766. eCollection 2020. J Cancer. 2020. PMID: 31949494 Free PMC article.
Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study.
Huang C, Zhu XD, Shen YH, Xu B, Wu D, Ji Y, Chen LL, Song TQ, Zhang W, Zeng ZM, Huang HS, Wang K, Huang LQ, Chen YJ, Yang YC, Zhou LD, Long G, Zhao HT, Wang YC, Ge NL, Chen Y, Tan CJ, Zhou J, Fan J, Sun HC. Huang C, et al. Among authors: zeng zm. BMC Cancer. 2023 May 9;23(1):416. doi: 10.1186/s12885-023-10898-z. BMC Cancer. 2023. PMID: 37158833 Free PMC article.
A retrospective cohort study on the efficacy and safety for combination therapy of immunotherapy, targeted agent, and chemotherapy versus immunochemotherapy or chemotherapy alone in the first-line treatment of advanced biliary tract carcinoma.
Zeng J, Ma J, Zeng Z, Yang L, Jiang Y, Mo N, Ma F, Liu C, Li R, Tang J, Qin S, Jiang H. Zeng J, et al. J Gastrointest Oncol. 2023 Apr 29;14(2):758-767. doi: 10.21037/jgo-23-218. Epub 2023 Apr 26. J Gastrointest Oncol. 2023. PMID: 37201053 Free PMC article.
Case Report: A case of hepatocellular carcinoma with aberrant right hepatic artery treated with transarterial chemoembolization and infusion chemotherapy separately to bilobar lesion combining with systemic therapies and sequential hepatectomy.
Wei YG, Su H, Lv ZL, Liao XW, Zeng ZM, Jia YX, Huang HS, Shen XQ, Zhu GZ, Han CY, Ye XP, Peng T. Wei YG, et al. Among authors: zeng zm. Front Oncol. 2023 Jul 4;13:1165538. doi: 10.3389/fonc.2023.1165538. eCollection 2023. Front Oncol. 2023. PMID: 37469401 Free PMC article.
Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter Study.
Xu B, Dong SY, Bai XL, Song TQ, Zhang BH, Zhou LD, Chen YJ, Zeng ZM, Wang K, Zhao HT, Lu N, Zhang W, Li XB, Zheng SS, Long G, Yang YC, Huang HS, Huang LQ, Wang YC, Liang F, Zhu XD, Huang C, Shen YH, Zhou J, Zeng MS, Fan J, Rao SX, Sun HC. Xu B, et al. Among authors: zeng zm. Liver Cancer. 2022 Nov 28;12(3):262-276. doi: 10.1159/000528034. eCollection 2023 Aug. Liver Cancer. 2022. PMID: 37601982 Free PMC article.
51 results